United States
US 12,697,314 B2
Pharmaceutical composition for treating autosomal dominant polycystic kidney disease
US 12,697,314 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY; KYOTO UNIVERSITY. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY; KYOTO UNIVERSITY
- Inventors
- Kenji OSAFUNE; Shinichi MAE; Saori NISHIO; Fumihiko HATTANDA; Tsuyoshi NAKANO; Ryuichiro HIRAYAMA; Tomoko SUZUKI; Ayuto HAYASHI
- Publication date
- 2026-08-04
- Filing date
- 2025-06-18
- Document type
- B2 Granted patent
- Also written as
- US 12,697,314 B2 · US12697314 · 12697314
Abstract
A new dosage regimen of a pharmaceutical composition comprising tamibarotene as the active ingredient for treating autosomal dominant polycystic kidney disease. A pharmaceutical composition comprising tamibarotene for the treatment or prevention of autosomal dominant polycystic kidney disease (ADPKD), wherein the composition is administered orally to a patient with ADPKD in an amount of 1.4-5.5 mg/day, particularly 4.0 mg/day of tamibarotene.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free